BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 9561978)

  • 1. Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy.
    Chamberlain MC; Kormanik P
    Arch Neurol; 1998 Apr; 55(4):506-12. PubMed ID: 9561978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy.
    Chamberlain MC; Kormanik PR
    J Neurooncol; 1997 Oct; 35(1):55-64. PubMed ID: 9266441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal metastases due to melanoma.
    Chamberlain M; Kormanik P
    Int J Oncol; 1996 Sep; 9(3):505-10. PubMed ID: 21541542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphomatous meningitis in immunocompetent patients.
    Chamberlain M; Kormanik P
    Oncol Rep; 1997; 4(6):1311-8. PubMed ID: 21590244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined-modality treatment of leptomeningeal gliomatosis.
    Chamberlain MC
    Neurosurgery; 2003 Feb; 52(2):324-29; discussion 330. PubMed ID: 12535360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Barba D
    J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-related central nervous system lymphomas.
    Chamberlain MC; Kormanik PA
    J Neurooncol; 1999 Jul; 43(3):269-76. PubMed ID: 10563433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
    Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
    Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
    Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
    Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment.
    Boogerd W; Hart AA; van der Sande JJ; Engelsman E
    Cancer; 1991 Mar; 67(6):1685-95. PubMed ID: 2001559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
    Chamberlain MC; Kormanik P; Glantz M
    Oncol Rep; 1998; 5(2):521-5. PubMed ID: 9468593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis.
    Chamberlain MC; Dirr L
    J Clin Oncol; 1993 Oct; 11(10):1978-84. PubMed ID: 7692000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric leptomeningeal metastases: outcome following combined therapy.
    Chamberlain MC
    J Child Neurol; 1997 Jan; 12(1):53-9. PubMed ID: 9010796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases.
    Chamberlain MC; Kormanik PA
    Neurology; 1996 Jun; 46(6):1674-7. PubMed ID: 8649568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
    Gwak HS; Joo J; Kim S; Yoo H; Shin SH; Han JY; Kim HT; Lee JS; Lee SH
    J Thorac Oncol; 2013 May; 8(5):599-605. PubMed ID: 23422833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidermal growth factor tyrosine kinase inhibitors used in the treatment of NSCLC patients with leptomeningeal metastasis].
    Xu Y; Zhong W; Zhao J; Chen MJ; Zhang L; Li LY; Wang MZ
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):920-924. PubMed ID: 27998469
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
    Park JH; Kim YJ; Lee JO; Lee KW; Kim JH; Bang SM; Chung JH; Kim JS; Lee JS
    Lung Cancer; 2012 Jun; 76(3):387-92. PubMed ID: 22186628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of leptomeningeal metastases in pediatrics.
    Chamberlain MC
    J Child Neurol; 1995 May; 10(3):191-9. PubMed ID: 7642887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.